From a horizontal accumulation phase, the timing seems good to buy shares in Aegon N.V. and to get ahead of a break-out on the upside of the congestion area. Investors have an opportunity to buy the stock and target the € 4.75.
For a short-term investment strategy, the company has poor fundamentals.
The stock, which is currently worth 2020 to 0.6 times its sales, is clearly overvalued in comparison with peers.
The company is one of the best yield companies with high dividend expectations.
The stock is in a well-established, long-term rising trend above the technical support level at 2.93 EUR
The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
ę MarketScreener.com 2021
Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.